Obtenez 3 mois à 0,99 $/mois + 20 $ de crédit Audible

OFFRE D'UNE DURÉE LIMITÉE
Page de couverture de Oncology Today with Dr Neil Love

Oncology Today with Dr Neil Love

Oncology Today with Dr Neil Love

Auteur(s): Dr. Neil Love
Écouter gratuitement

À propos de cet audio

Medical oncologist Dr Neil Love interviews clinical investigators on new research and practical application to general medical oncology practice.Copyright 2025 Research To Practice. All Rights Reserved Hygiène et mode de vie sain Science Troubles et maladies
Épisodes
  • HR-Positive Metastatic Breast Cancer — An Interview with Dr Erika Hamilton on the Potential Role of PROTAC Estrogen Receptor Degraders
    Nov 19 2025

    Dr Erika Hamilton from Sarah Cannon Research Institute in Nashville, Tennessee, reviews available clinical data with PROTAC estrogen receptor degraders and their potential role in the management of HR-positive metastatic breast cancer. 

    CME information and select publications here.

    Voir plus Voir moins
    59 min
  • Patient Education Resource: Non-Hodgkin Lymphoma — Clinical Experts Address Common Questions Posed by Patients About CAR T-Cell Therapy
    Nov 15 2025

    Dr Jeremy S Abramson from Massachusetts General Hospital in Boston and Dr Manali Kamdar from the University of Colorado Cancer Center in Aurora discuss patient questions and experiences with CAR T-cell therapy for non-Hodgkin lymphoma.

    Educational information and select publications here.

    Voir plus Voir moins
    1 h
  • ER-Positive Metastatic Breast Cancer — A Roundtable Discussion on the Current and Future Role of Oral SERDs
    Nov 14 2025

    Prof Francois-Clement Bidard from the Institut Curie in Paris, France, Dr Hope S Rugo from the City of Hope Comprehensive Cancer Center in Duarte, California, Dr Rebecca Shatsky from the University of California San Diego Moores Cancer Center and Dr Seth Wander from Massachusetts General Hospital in Boston discuss recent updates on available and emerging treatment strategies involving oral SERDs for ER-positive metastatic breast cancer.

    CME information and select publications here.

    Voir plus Voir moins
    2 h et 31 min
Pas encore de commentaire